Japan’s Eneos to Acquire TPC; FDA Approves Twice-Rejected Melanoma Drug
Aug 11, 2026
Japan’s Eneos plans to acquire TPC and the FDA approved a melanoma drug, while major chemical makers like BASF reported soaring Q2 profits driven by Middle East supply disruptions.
2026-08-07
ENEOS to acquire US TPC Group2026-08-17
Asia Top Stories – Weekly Summary